Meet the people behind Bioforce

Bioforce has a board of trustees comprising 20 members who help develop the strategy and vote on the broad guidelines. Daily operations are covered by a team of 70 people in Europe, Africa and the Middle East, at the headquarters, in training centres and in our missions. Finally, we have a network of external trainers, some of whom are accredited as Associate Trainers.

Meet the team

ANNUAL REPORT

  • Download our annual report in English

    Download

RESOURCES & PARTNERS

Origin of funds

  • Private funding (Individuals). Funding from course participants
  • Donors. Auvergne-Rhône-Alpes Regional Authorities, Lyon metropolitan authorities (Métropole de Lyon), Regional and Town Councils, other public institutions, public establishments, Caisse des Dépôts, Agence Française de Développement, French Europe and Foreign Affairs ministry, UN agencies, Principality of Monaco.
  • Private funding (Organisations). International organisations, NGOs, companies, foundations, taxe d’apprentissage (French tax to fund continual professional development), OPCO (French funding body for vocational contracts).
  • Philanthropy and membership fees. Institut Mérieux, bioMérieux, Sogelym Dixence, membership fees
  • Other income Miscellaneaous operating income.

Use of funds

  • Learn. Diploma and open training courses for the humanitarians of today and tomorrow.
  • Build. Strengthening the capacities of organisations in crisis-affected zones.
  • Operative costs. Overhead costs incurred in carrying out our missions and ensuring they are properly implemented.
  • Other expenses. Depreciation, amortisation and impairment expenses.
  • Capital funds Profit for the year
  • The positive result for the year of €666,109 was allocated to capital funds.

They support Bioforce

Our story

Humanitarian since 1983

It all began at a local level, when a pioneer of preventive medicine and industrial virology from Lyon, Charles Mérieux, came to the conclusion that no aid work was possible without logistics support.

Read the story